Sun Pharmaceutical Industries Navigates Mixed Momentum Amidst Market Challenges
Sun Pharmaceutical Industries is trading at Rs 1643.2, reflecting mixed short-term momentum as it is above its 5-day moving average but below longer-term averages. With a market cap of Rs 3,92,759.00 crore, the company has faced a year-to-date decline but shows strong long-term growth.
Sun Pharmaceutical Industries has shown notable activity today, trading at Rs 1643.2, consistent with its sector performance. The stock's current price is above its 5-day moving average but below its 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed short-term momentum.With a market capitalization of Rs 3,92,759.00 crore, Sun Pharma operates within the Pharmaceuticals & Biotechnology industry, where it holds a P/E ratio of 34.24, slightly below the industry average of 35.34.
In terms of recent performance, Sun Pharmaceutical Industries has faced challenges over the past year, with a decline of 5.79%, contrasting with the Sensex's gain of 1.40%. However, the stock has shown some resilience in the short term, with a 1-day increase of 0.20% and a 1-week rise of 1.71%.
Despite a year-to-date decline of 12.96%, the company has demonstrated strong growth over longer periods, with a 5-year performance of 211.74%, significantly outperforming the Sensex's 111.70% increase. Overall, Sun Pharmaceutical Industries continues to navigate a complex market landscape.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
